(Q36549218)
Statements
1 reference
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. (English)
1 reference
Eastern Cooperative Oncology Group
1 reference
B J Giantonio
1 reference
D E Levy
1 reference
P J O'dwyer
1 reference
N J Meropol
1 reference
P J Catalano
1 reference
A B Benson
1 reference
27 July 2006
1 reference
1 reference
17
1 reference
9
1 reference
1399-1403
1 reference
Identifiers
1 reference
1 reference